Procter & Gamble Health (NSE:PGHL) Change In Working Capital : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Procter & Gamble Health Change In Working Capital?

Procter & Gamble Health's change in working capital for the quarter that ended in Mar. 2025 was ₹0 Mil.

Procter & Gamble Health's change in working capital for the fiscal year that ended in Jun. 2024 was ₹-121 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Procter & Gamble Health Change In Working Capital Historical Data

The historical data trend for Procter & Gamble Health's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procter & Gamble Health Change In Working Capital Chart

Procter & Gamble Health Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Jun21

Jun22

Jun23

Jun24

Change In Working Capital

Get a 7-Day Free Trial

-502.60

412.20

-473.00

-300.20

-121.20

Procter & Gamble Health Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

Procter & Gamble Health Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Procter & Gamble Health Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Procter & Gamble Health's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Procter & Gamble Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (NSE:PGHL) » Definitions » Change In Working Capital

Traded in Other Exchanges

500126:India

Address

Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099

Website

https://www.pghealthindia.com

Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

Procter & Gamble Health Headlines

No Headlines